Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 19];2(S1):S47. Available from: https://skin.dermsquared.com/skin/article/view/303